Craig Stobie, head of the global life science team at Domino Printing Sciences, shares his thoughts on the solutions for continuous manufacturing.
Earlier this month, MIT Professor Tim Jamison shared his concern that despite continuous manufacturing being the future for pharma, a lack of scientific knowledge will hold the industry back from adopting continuous processes. While continuous manufacturing has been on the pharma agenda for at least two decades, the requirement for traceability by batch has always been one of the stumbling blocks.